The “metabolic pathway” involved the largest number of target genes, followed by the “PI3K-Akt signaling pathway,” “Ras signaling pathway,” “cytokine-cytokine receptor interaction,” “non-small cell lung cancer,” and other pathways (Fig. 2C). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.